Advisory, retainer, and expert work

Engagements with a different rhythm than a defined project. Some are matter-specific (a single litigation, a single regulatory submission). Some are ongoing (post-accreditation maintenance, on-call SME access). All bill on quarter-hour increments with a running ledger on every invoice.

Expert Witness + Litigation Support

Independent technical opinions, deposition and testimony, document review. Engage a single expert by domain, or a coordinated team of four under one engagement — with the proof point that all four cofounders have already collaborated on prior expert-witness matters together.

EngagementScoped at intake. Every engagement is sized to the work, so we quote to scope rather than publish a list price.

What we deliver

·Pre-litigation scoping and data audit
·Exposure-disease mapping for toxic-tort matters
·Regulatory benchmarking (OSHA PELs, EPA, FDA, state regulators)
·Gap and external-SME identification
·Scoping reports written under attorney-client privilege (Prepared in Anticipation of Litigation)
·Phase-2 transition pathway from consulting expert to testifying expert by separate addendum
·Conflict-checked engagement letters and engagement-specific scope

Who leads

By matter domain. Tess Eidem, PhD on microbiology, bioaerosols, IAQ, building-environment exposure. Julie Kowalski, PhD on analytical chemistry, chromatography, pesticide residue. Kate Evans, PhD on toxicology, pharmaceutical analysis, cannabis cross-domain. Andrew Samann on cannabis cGMP, QMS, manufacturing.

“Vetted alignment, not assembled team. Testifying together against a common opposing expert is the proving ground for trust under pressure.”

Post-Accreditation / Compliance Retainer

Quarterly retainer with on-call senior SME access for post-accreditation maintenance, surveillance-audit prep, regulatory updates, OOS and CAPA review, and ad-hoc compliance questions.

EngagementScoped at intake. Every engagement is sized to the work, so we quote to scope rather than publish a list price.

What we deliver

·Quarterly review meeting with the client's quality leadership
·Bank of senior consultant hours rolled forward quarter to quarter
·On-call escalation channel for regulatory and audit triggers
·Annual review of QMS document set against current standard revisions

Who leads

Lead cofounder assigned by domain at engagement start; full team available for cross-domain questions.

“Intrepid advises, builds, and trains. The client operates the system.”

Federal Pathway / Schedule III Advisory

Advisory work tied to the April 2026 cannabis rescheduling — Single Convention SOPs, Public Interest defense documentation, DEA § 1301.13(k) registration package preparation, EU export pathway under § 1312.30, IND-track planning, and the integrated ICH / EU GMP / 21 CFR 211 build that follows.

EngagementScoped at intake. Every engagement is sized to the work, so we quote to scope rather than publish a list price.

What we deliver

·Section 823(e)–(g) Public-Interest defense memo
·Single Convention buy/sell-back SOP and batch-record template
·Cultivation-area specification package (§ 1301.13(k)(6)(C))
·DEA § 1301.13(k) registration submission package review
·EU GMP gap assessment for export-pathway operators
·IND/NDA-track planning for FDA-approved drug product candidates

Who leads

Andrew Samann on DEA framework, cGMP, ICH stack. Kate Evans, PhD on FDA test method submission. Julie Kowalski, PhD on analytical chemistry method validation for pharma.

“The 60-day window is a registration sprint. The pharma pathway is a multi-year build. Don't conflate them.”

Talk to us about an engagement

Send a note describing what you’re working on. We reply directly, from a cofounder. Every engagement is scoped at intake.

Send a note See all services